🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
The past 15 years, using National Health Insurance Service (NHIS) database ...
Status
Completed
Location
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Start Date
2021-08-04
Trial ID
NCT04984174
Purpose of the study Phase I study: to explore the optimal dose combination...
Status
Recruiting
Location
Beijing
Start Date
2024-06-23
Trial ID
NCT06782685
This is an open-label, multicenter, randomized, Phase 3 study in patients w...
Status
Completed
Location
Arizona Cancer Center
Start Date
2018-09-15
Trial ID
NCT03665441
Treatments Being Tested
The objective is to describe mPDAC patients still alive one year after the ...
Status
Unknown
Location
Klinikum der Universität München, - Anstalt des öffentlichen Rechts -
Start Date
2023-10-06
Trial ID
NCT06155136
To evaluate the safety and efficacy of simmitinib plus irinotecan liposome ...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2024-03-15
Trial ID
NCT06512428
Treatments Being Tested
The investigators explored the safety and activity of weekly irinotecan lip...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2024-03-25
Trial ID
NCT06340204
Treatments Being Tested
To evaluate the efficacy and safety of irinotecan hydrochloride liposome in...
Status
Not Yet Recruiting
Location
The First Hospital of China Medical University
Start Date
2024-07-01
Trial ID
NCT06463548
Treatments Being Tested
Pancreatic cancer is difficult to diagnose early. By the time people have b...
Status
Recruiting
Location
University of Arizona Cancer Center - North Campus
Start Date
2026-02-17
Trial ID
NCT07409272
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of MM-398 and ...
Status
Withdrawn
Location
USC / Norris Comprehensive Cancer Center
Start Date
2020-04-06
Trial ID
NCT03739801
Treatments Being Tested